FDA-approved, clinician-supervised semaglutide therapy — helping New Jersey patients achieve lasting weight loss through personalized, evidence-based care.
Request a Free ConsultationSemaglutide is a GLP-1 receptor agonist — a class of medication originally developed to treat type 2 diabetes that has since demonstrated remarkable results in clinical weight loss trials. It works by mimicking glucagon-like peptide-1, a natural hormone your body produces after eating.
In New Jersey and across the country, semaglutide has become one of the most prescribed weight loss medications available. Available under brand names including Ozempic and Wegovy, semaglutide is now accessible through telehealth providers like NJ Weight Loss & Preventive Care Clinics PA.
Our Clinical Director, Jim Bock, RN, oversees every patient's treatment plan, ensuring personalized dosing, safety monitoring, and ongoing support throughout your weight loss journey.
Semaglutide targets areas of the brain that regulate appetite and food intake. It slows gastric emptying — the rate at which your stomach empties after eating — which means you feel fuller longer and experience fewer cravings.
Unlike stimulant-based weight loss medications of the past, semaglutide addresses the biological mechanisms behind weight gain and obesity. For many patients, this translates into sustainable, meaningful weight reduction when combined with healthy lifestyle habits.
Clinical trials supporting FDA approval showed patients losing an average of 15% of their body weight over 68 weeks — results unmatched by any previous weight loss medication.
Semaglutide offers a range of benefits beyond the number on the scale. Patients treated at NJ Weight Loss & Preventive Care experience comprehensive improvements in health and well-being.
Clinical data supports consistent, meaningful weight loss — typically 10–20% of starting body weight — over the course of treatment.
Semaglutide reduces hunger signals, making it easier to maintain healthy food choices and appropriate portion sizes.
Patients often see improvements in blood sugar regulation, cholesterol levels, and blood pressure as weight decreases.
Research published in major medical journals has demonstrated reduced risk of major cardiovascular events in patients using semaglutide.
Every NJ Weight Loss patient is monitored by our licensed clinical team, ensuring your treatment is safe, effective, and appropriately adjusted.
No in-person office required. Our telehealth platform lets New Jersey patients — and patients nationwide — access treatment from home.
Semaglutide is FDA-approved for adults with a BMI of 30 or higher, or adults with a BMI of 27 or higher who also have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol.
At NJ Weight Loss & Preventive Care Clinics PA, our team conducts a thorough intake evaluation to determine whether semaglutide is the right fit for your health profile. Because every patient is different, we tailor our treatment protocols based on your medical history, current health status, and personal weight loss goals.
Semaglutide may not be appropriate for individuals with a personal or family history of certain thyroid conditions, or those who are pregnant or planning to become pregnant. Our clinical team will review all contraindications during your consultation.
We currently serve patients in all 50 states through our HIPAA-compliant telehealth platform, making expert semaglutide care accessible no matter where you live.
Take the first step. Submit your information below and a member of our clinical team will reach out to discuss whether semaglutide is right for you — no obligation, no pressure.
Your information is protected and never shared. We will only contact you regarding your weight loss inquiry.